There are currently 435 reactors operating, 62 reactors under construction, 156 reactors at the planning stage and 343 reactors under proposal.
Atlanta, GA (PRWEB) May 08, 2012
MissionIR would like to highlight Uranium Energy Corp., a publicly traded U.S.-based exploration and development company focused on uranium production in the U.S. The company's operations are managed by professionals who have earned a reputable profile through many decades of hands-on experience in the key facets of uranium exploration, development, and mining.
Today, Seeking Alpha published the following article featuring Uranium Energy as the focus ticker: http://seekingalpha.com/article/567321
The article titled “Uranium Energy: An Under The Radar Uranium Play With Tremendous Upside” provides an overview of the uranium industry after the Fukushima nuclear power accident, as well as upside potential for near-term and long-term growth.
There are currently 435 reactors operating, 62 reactors under construction, 156 reactors at the planning stage and 343 reactors under proposal. China, India, Russia and South Korea, the four major drivers of nuclear growth, have evaluated and renewed their commitment to nuclear power.
For 2011, global uranium consumption was approximately 175 million pounds while uranium production is estimated to reach only about 145 million pounds. To date, this shortfall has been made up from secondary sources of uranium such as government inventories, recycled materials, and down-blended weapons-grade material provided under the HEU Agreement between the U.S. and Russia, currently providing approximately 24 million pounds of supply annually and set to expire in 2013.
One uranium stock that's loved by investors and analysts alike is Uranium Energy, a U.S.-based exploration and development company focused on uranium production in the U.S. The company is the newest uranium producer in North America, operating the first new uranium mine in the U.S. in over six years. In 2011, Uranium Energy completed its first full year of production with a cumulative total of 236,000 lbs. of uranium produced at average cost of $16 per pound, which the company then sold at the current spot price of $52 per pound. Uranium utilizes the In-Situ Recovery (ISR) production method, which is a more cost-effective and environmentally friendly way of mining uranium.
The combination of the drop in UEC's share price and the projected supply/demand imbalance creates an unparalleled opportunity in UEC. Just returning to pre-Fukushima levels would give investors a return of 150%, a return that any investor would get excited about. Taking into consideration the projected price increase in uranium and that projected return increases even further.
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
To sign up for The MissionIR Report, please visit http://MissionIR.com
To connect with MissionIR via Facebook, please visit http://Facebook.com/MissionIR
To connect with MissionIR via Twitter, please visit http://Twitter.com/MissionIR
Please read FULL disclaimer on the MissionIR website: http://Disclaimer.MissionIR.com
This release may contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All forward-looking statements are inherently uncertain as they are based on current expectations and assumptions concerning future events or future performance of the company. Readers are cautioned not to place undue reliance on these forward-looking statements, which are only predictions and speak only as of the date hereof. Risks and uncertainties applicable to the company and its business could cause the company's actual results to differ materially from those indicated in any forward-looking statements.